Zou S - Search Results

1

This is the first in-human trial and prospective case series of a novel single-port robotic system for gynaecological surgery: An IDEAL stage 2a study.

Hu X, Ruan M, Zhu L, Huang M, Qi L, Huang M, Zou S, Lin L, Zheng W, Wang L, Duan P. Hu X, et al. Among authors: zou s. Int J Med Robot. 2024 Oct;20(5):e2657. doi: 10.1002/rcs.2657. Int J Med Robot. 2024. PMID: 39303291 Clinical Trial.

2

Uterine tumor resembling ovarian sex cord tumor: a clinicopathological and immunohistochemical analysis of two cases and a literature review.

Zhang X, Zou S, Gao B, Qu W. Zhang X, et al. Among authors: zou s. J Int Med Res. 2019 Mar;47(3):1339-1347. doi: 10.1177/0300060518821824. Epub 2019 Feb 8. J Int Med Res. 2019. PMID: 30732515 Free PMC article. Review.

3

A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.

Zhao M, Huang W, Zou S, Shen Q, Zhu X. Zhao M, et al. Among authors: zou s. Int J Genomics. 2020 Mar 25;2020:8347639. doi: 10.1155/2020/8347639. eCollection 2020. Int J Genomics. 2020. PMID: 32300605 Free PMC article.

4

Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.

Zou S, Shen Q, Hua Y, Jiang W, Zhang W, Zhu X. Zou S, et al. Reprod Sci. 2013 Nov;20(11):1356-64. doi: 10.1177/1933719113485291. Epub 2013 Apr 18. Reprod Sci. 2013. PMID: 23599374 Free PMC article.

5

Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.

Zou S, Ye M, Zhang JA, Ji H, Chen Y, Zhu X. Zou S, et al. BMC Med Genomics. 2022 Sep 8;15(1):191. doi: 10.1186/s12920-022-01342-5. BMC Med Genomics. 2022. PMID: 36076209 Free PMC article.

6

The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models.

Ye M, Liu T, Miao L, Zou S, Ji H, Zhang J, Zhu X. Ye M, et al. Among authors: zou s. Cancers (Basel). 2023 Nov 28;15(23):5625. doi: 10.3390/cancers15235625. Cancers (Basel). 2023. PMID: 38067329 Free PMC article.

7

The Application of Patient-Derived Xenograft Models in Gynecologic Cancers.

Jiang W, Xie S, Liu Y, Zou S, Zhu X. Jiang W, et al. Among authors: zou s. J Cancer. 2020 Jul 11;11(18):5478-5489. doi: 10.7150/jca.46145. eCollection 2020. J Cancer. 2020. PMID: 32742495 Free PMC article. Review.

8

Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.

Xie S, Pan S, Zou S, Zhu H, Zhu X. Xie S, et al. Among authors: zou s. Clin Interv Aging. 2020 Jun 3;15:841-851. doi: 10.2147/CIA.S255305. eCollection 2020. Clin Interv Aging. 2020. PMID: 32606624 Free PMC article.

9

Immunohistochemical expression of RAGE and its ligand (S100A9) in cervical lesions.

Zhu X, Jin L, Zou S, Shen Q, Jiang W, Lin W, Zhu X. Zhu X, et al. Among authors: zou s. Cell Biochem Biophys. 2013 Jul;66(3):843-50. doi: 10.1007/s12013-013-9515-x. Cell Biochem Biophys. 2013. PMID: 23340902

10

Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis.

Shen Q, Hu X, Zhou L, Zou S, Sun LZ, Zhu X. Shen Q, et al. Among authors: zou s. Cell Signal. 2018 May;45:43-53. doi: 10.1016/j.cellsig.2018.01.025. Epub 2018 Jan 31. Cell Signal. 2018. PMID: 29382566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,147 results

Search Page

Filters